Kejia Kan
- Immunology top 10%
- Parasitology top 10%
-
- Aortic Disease and Treatment Approaches 2
- Aortic aneurysm repair treatments 2
-
- MicroRNA in disease regulation 2
- Cancer-related molecular mechanisms research 2
-
- Infectious Aortic and Vascular Conditions 2
- Peripheral Artery Disease Management 2
-
- Sepsis Diagnosis and Treatment 2
-
- Diabetic Foot Ulcer Assessment and Management 1
- Co-authors
- Christopher D. BenjaminRoy R. LobbMasanori AikawaM HoCF OckenhouseTatsuya TegoshiYoshimasa MaenoHaozhe Qi
- Partner nations
- GermanyChinaUnited States
In The Last Decade
Kejia Kan
14 papers receiving 472 citations
Peers
Comparison fields: 5 of 69
- Immunology 240
- Public Health, Environmental and Occupational Health 281
- Parasitology 32
- Immunology and Allergy 23
- Virology 15
Countries citing papers authored by Kejia Kan
This map shows the geographic impact of Kejia Kan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kejia Kan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kejia Kan more than expected).
Fields of papers citing papers by Kejia Kan
This network shows the impact of papers produced by Kejia Kan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kejia Kan. The network helps show where Kejia Kan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kejia Kan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 17 | |
| 3 | 2022 | 5 | |
| 4 | 2022 | 5 | |
| 5 | 2022 | 5 | |
| 6 | 2022 | 7 | |
| 7 | 2022 | 2 | |
| 8 | 2021 | 7 | |
| 9 | 2021 | 7 | |
| 10 | 2020 | 3 | |
| 11 | 2020 | 18 | |
| 12 | 2017 | 0 | |
| 13 | 2017 | 6 | |
| 14 | 2016 | 80 | |
| 15 | 1992 | 314 |
About Kejia Kan
Kejia Kan is a scholar working on Cancer Research, Developmental Neuroscience and Immunology and Allergy, having authored 15 papers that have together received 478 indexed citations. Recurring topics across this work include Aortic Disease and Treatment Approaches (2 papers), MicroRNA in disease regulation (2 papers), Aortic aneurysm repair treatments (2 papers), Infectious Aortic and Vascular Conditions (2 papers), Sepsis Diagnosis and Treatment (2 papers), Peripheral Artery Disease Management (2 papers), Cancer-related molecular mechanisms research (2 papers) and Diabetic Foot Ulcer Assessment and Management (1 paper). The work is most often cited by research in Immunology (240 citations), Public Health, Environmental and Occupational Health (281 citations) and Parasitology (32 citations). Kejia Kan has collaborated with scholars based in Germany, China and United States. Frequent co-authors include Christopher D. Benjamin, Roy R. Lobb, Masanori Aikawa, M Ho, CF Ockenhouse, Tatsuya Tegoshi, Yoshimasa Maeno, Haozhe Qi, Xiangjiang Guo and Jiaquan Chen. Their work appears in journals such as Biomedicines, Cancers, International Journal of Surgery, Scientific Reports and Reviews in Cardiovascular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.